Mark A Glickman's Net Worth
$1.9 Million
Who is Mark A Glickman?
Mark A Glickman has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., Aralez Pharmaceuticals Inc., TherapeuticsMD, Inc., NeuroBo Pharmaceuticals, Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
Mark A Glickman's CIK is 0001441461
Past Insider Trading and Trends
2014 was Mark A Glickman's most active year for acquiring shares with 8 total transactions. Mark A Glickman's most active month to acquire stocks was the month of January. 2014 was Mark A Glickman's most active year for disposing of shares, totalling 8 transactions. Mark A Glickman's most active month to dispose stocks was the month of December. 2014 saw Mark A Glickman paying a total of $837,250.00 for 127,325 shares, this is the most they've acquired in one year. In 2014 Mark A Glickman cashed out on 91,780 shares for a total of $1,666,870.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.63% | 5.92K |
—
|
—
| 25.93K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aralez Pharmaceuticals Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.24% | -5.72K |
$1.70 | -$9,732.50 | 250.19K |
Scheduled
|
Mar 19
| ||
Form 4
| +45.61% | 80.16K |
—
|
—
| 255.91K |
May 11
| |||
Form 4
| -5.79% | -10.80K |
$3.34 | -$36,082.02 | 175.75K |
Jun 22
| |||
Form 4
| +15.47% | 25K |
$3.68 | $92,050.00 | 186.55K |
May 16
| |||
Form 4
| +39.27% | 45.55K |
—
|
—
| 161.55K |
Mar 17
| |||
Form 4
| +298.12% | 86.86K |
—
|
—
| 116K |
Feb 12
| |||
Form 4
|
∞
| 29.14K |
—
|
—
| 29.14K |
Feb 5
| |||
No matching records found |
TherapeuticsMD, Inc. (TXMD) Snapshot price: $1.9
Co-Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.29K |
$4.92 | -$2,165.46 | 1.29K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NeuroBo Pharmaceuticals, Inc. (NRBO) Snapshot price: $3.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +107.72% | 5.05K |
—
|
—
| 9.74K |
Jun 7
| |||
Form 4
|
∞
| 37.5K |
—
|
—
| 37.5K |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AUXILIUM PHARMACEUTICALS INC No price found
EVP - Sales and Marketing
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -27.91K |
$36.53 | -$1,019,588.83 |
0
|
Jan 29
| |||
Form 4
| -20.51% | -7.20K |
$26.86 | -$753,084.96 | 27.91K |
Nov 20
| |||
Form 4/A
| +88.15% | 25.7K |
—
|
—
| 54.85K |
Feb 7 - Feb 18
| |||
Form 4
| +107.25% | 18.17K |
$28.30 | -$19,923.20 | 35.11K |
Feb 18
| |||
Form 4
| -10.49% | -1.99K |
$23.68 | -$47,028.48 | 16.94K |
Feb 7
| |||
Form 4
| -2.01% | -388.00 |
$24.70 | -$9,583.60 | 18.93K |
Feb 3
| |||
Form 4
| +642.35% | 16.71K |
$18.30 | -$7,795.80 | 19.32K |
Feb 7
| |||
Form 4
| -13.27% | -398.00 |
$18.85 | -$7,502.30 | 2.6K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |